Interactions of epidermal cells and T cells in inflammatory skin diseases

Journal of the American Academy of Dermatology

Volumn 23, Issue 6, 1990, Pages 1312-1317

  Baadsgaard, Ole ^a   Voorhees, John J ^a   Cooper, Kevin D ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CONFERENCE PAPER; EPIDERMIS; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE;

DERMATITIS; HUMAN; KERATINOCYTES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; PSORIASIS; SKIN; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0025603076     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(90)70359-P     Document Type: Article

References (47)

1. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF)
2. Epidermal cell production of thymocyte-activating factor (ETAF)
3. Keratinocytes produce interleukin 6, a cytokine which can provide a 2nd signal in the activation of T-cells [Abstract]
4. Keratinocyte-derived granulocyte/macrophage colony-stimulating factor induces DNA synthesis by peritoneal macrophages
5. Production of IL-8 by human dermal fibroblasts and keratinocytes in response to IL-1 or human necrosis factor
6. Epidermal cell derived lymphocyte differentiating factor (ELDIF) inhibits in vitro lymphoproliferative responses and interleukin-2 production
7. Cultured keratinocytes secrete a substance which inhibits allogeneic lymphocyte proliferation [Abstract]
8. Human keratinocyte-lymphocyte reactions in vitro
9. Isolation and purification of ILS, an interleukin 1 inhibitor produced by human gingival epithelial cells
10. Arachidonic acid transformations in normal and psoriatic skin
11. Antigen presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions
12. Decreased number and function of epidermal antigen presenting cells in the skin following application of irritant agents: relevance to cutaneous tumors?
13. Epidermal activation of autoreactive T cells in atopic dermatitis: response to cyclosporine A [Abstract]
14. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen presenting cells
15. − antigen presenting cells
16. Phenotype, ultrastructure and function of CD1+DR+ epidermal cells that coexpress OKM5 in cutaneous T cell lymphoma
17. Expression of OKM5 antigen on epidermal cells in mycosis fungoides plaque stage
18. + cells which enhance epidermal alloantigen presentation
19. + melanophages appear in human epidermis after ultraviolet radiation
20. + antigen-presenting cells in human epidermis
21. + human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation
22. Rapid recovery of Langerhans cells alloreactivity, without induction of autoreactivity, following in vivo UVA, but not UVB exposure of human skin
23. + suppressor/cytotoxic lymphocytes
24. An alternative pathway of T-cell activation: a functional role for the 50 kD Til sheep erythrocyte binding protein
25. A novel pathway of human T-lymphocyte activation: identification by a monoclonal antibody generated against a rheumatoid synovial T cell line
26. Expression and function of the UM4D4 antigen in human thymus
27. + (CDw60) T-cells are compartmentalized into psoriatic skin and release lymphognes that induce a keratinocyte phenotype expressed in psoriatic lesions
28. Activation of T cells from Sézary patients can occur through both antigen dependent and independent pathways
29. Selective in vitro growth of T lymphocytes from normal human bone marrows
30. Induction of inter-leukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction
31. + T cell clones
32. Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells
33. Interferon and natural killer (NK) cells
34. Epidermal T lymphocytes and HLA-DR expression in psoriasis
35. Psoriasis epidermal cells demonstrate increased number and function of non-Langerhans cell antigen presenting cells
36. Cyclosporine A therapy selectively reduces epidermal and dermal immune cells in psoriasis
37. Lesional psoriasis T cell cultures reflect the in situ subset distribution and demonstrate autoreactivity [Abstract]
38. Expression of UM4D4, a novel T cell activating molecule in normal skin: abnormal expression in psoriasis [Abstract]
39. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor
40. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques
41. Expression of HLA-DR antigen in skin from patients with psoriasis
42. Recombinant gamma interferon induces HLA-DR expression on cultured keratinocytes
43. Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events
44. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1)
45. Conditioned media from lesional psoriatic T-cell clones induces kerati-nocyte proliferation and expression of the surface activation molecule, UM4D4 [Abstract]